Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy A Cooper

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
The Lancet. Oncology|October 14, 2023
Lessons and opportunities from improved understanding of global lung cancer histological subtypesWendy A Cooper
Translational Lung Cancer Research|April 15, 2015
Preface-molecular genetics of lung cancerWendy A Cooper
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2014
Response to MaheWendy A Cooper, Benjamin Solomon
Respirology Case Reports|November 3, 2017
The novel 19G endobronchial USS (EBUS) needle samples processed as tissue "core biopsies" facilitate PD-L1 and other biomarker testing in lung cancer specimens: case report and the view point from the Respiratory Physician and the PathologistSamantha Herath, Wendy A Cooper
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2023
Rethinking Biomarkers for Combination ChemoimmunotherapyWendy A Cooper, Thomas John
Pathology|August 23, 2002
An unusual pleural spindle cell tumour. Part 1Wendy A Cooper, Richard A Scolyer
Pathology|April 22, 2005
Asbestos exposure and lung cancerC Soon Lee, Wendy A Cooper
Pathology|January 11, 2024
Predictive and prognostic biomarkers in solid tumoursWendy A Cooper, Puay Hoon Tan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2018
Response to Editorial: The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?Shona Hendry, Wendy A Cooper, Stephen B Fox
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC-Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?Wendy A Cooper, Sylvie Lantuejoul, Mari Mino-Kenudson
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|October 14, 2023
Lessons and opportunities from improved understanding of global lung cancer histological subtypesWendy A Cooper
Translational Lung Cancer Research|April 15, 2015
Preface-molecular genetics of lung cancerWendy A Cooper
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2014
Response to MaheWendy A Cooper, Benjamin Solomon
Respirology Case Reports|November 3, 2017
The novel 19G endobronchial USS (EBUS) needle samples processed as tissue "core biopsies" facilitate PD-L1 and other biomarker testing in lung cancer specimens: case report and the view point from the Respiratory Physician and the PathologistSamantha Herath, Wendy A Cooper
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2023
Rethinking Biomarkers for Combination ChemoimmunotherapyWendy A Cooper, Thomas John
Pathology|August 23, 2002
An unusual pleural spindle cell tumour. Part 1Wendy A Cooper, Richard A Scolyer
Pathology|April 22, 2005
Asbestos exposure and lung cancerC Soon Lee, Wendy A Cooper
Pathology|January 11, 2024
Predictive and prognostic biomarkers in solid tumoursWendy A Cooper, Puay Hoon Tan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2018
Response to Editorial: The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?Shona Hendry, Wendy A Cooper, Stephen B Fox
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC-Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?Wendy A Cooper, Sylvie Lantuejoul, Mari Mino-Kenudson
Pageof 14